Clinical Trial Update: Sequence Effect in Parkinson's Disease

View source ↗

Summary

The update notes that the NINDS-sponsored clinical trial examining the sequence effect in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson's Disease | Status: COMPLETED